Neonatal jaundice continues to be a substantial worry in newborn treatment, affecting around 60% of total-time period infants. The need for accurate, non-invasive bilirubin measurement has driven professional medical diagnostic tools companies to create State-of-the-art answers. Transcutaneous bilirubinometers have emerged as being a game-switching